Hypodermic Needles Market Statistics | Trends Report 2023-2035

Global Hypodermic Needles Market Size, Forecast, and Trend Highlights Over 2023 – 2035

Hypodermic Needles Market size is estimated to reach ~USD 9 Billion by the end of 2035 by growing at a CAGR of ~4% over the forecast period, i.e., 2023 – 2035. In addition to this, in the year 2022, the market size of hypodermic needles was ~USD 4 Billion. The growth of the market can be attributed to the rising prevalence of chronic and infectious diseases such as Hepatitis B and Hepatitis C, along with the increasing number of diagnostic tests to treat such diseases. The Centers for Disease Control and Prevention estimates that 296 million people worldwide are infected with hepatitis B, while 58 million are infected with hepatitis C. According to the World Health Organization, global hepatitis C infections affect about 58 million people, and 1.5 million new infections occur each year. In addition, 1.5 million new cases of chronic hepatitis B are reported each year, with 296 million chronic hepatitis B infections in 2019. The increasing number of patients with chronic and infectious diseases has led to a surge in demand for hypodermic needles, as they are used to administer medications and vaccines to these patients. These needles are designed to deliver medication directly into the bloodstream, allowing for more efficient delivery of the medication and reducing the risk of infection.

In addition to these, factors that are believed to fuel the growth of hypodermic needles market include an increasing prevalence of chronic and Noncommunicable diseases (NCDs), a growing geriatric population, rising demand for injectable drugs, and increasing investments in healthcare infrastructure. The CDC reports that 6 out of 10 adults in the United States have at least one chronic disease. WHO estimates that NCDs account for 41 million deaths each year, representing 74% of all global deaths. With the rise in chronic NCDs, the need for medical treatments and procedures has also increased significantly. This has given rise to a higher demand for hypodermic needles market, as they are needed to administer medications and fluids to the patient.

Global Hypodermic Needles Market: Growth Drivers and Challenges

Growth Drivers

Rise in the Preference for Minimally Invasive Surgery - It was observed that the number of minimally invasive procedures has increased from 133 to 280 over the last decade, i.e., an increase of 111% over the span of 2003 to 2019. Minimally invasive surgery involves techniques that use smaller incisions and specialized instruments. The smaller incisions require smaller and more precise instruments, such as hypodermic needles, which are used to deliver anesthetic or other treatments to the area being treated.
Intensifying COVID-19 Vaccination Shots - The World Health Organization reports that 13,325,228,015 vaccine doses have been injected as of 23 April 2023. India has administered more than 2200 million doses of COVID-19 vaccine since February 20, 2023. With more countries rolling out nationwide vaccination programs, the demand for hypodermic needles market has increased significantly. Hypodermic needles are therefore needed for the delivery of vaccines since they can deliver vaccines effectively and efficiently.
Rising Number of Government Initiatives to Support the Use of Safety Needles and Syringes - For instance, in December 2021, a model law for states to expand the availability of syringe services programs (SSPs) has been released by the White House Office of National Drug Control Policy (ONDCP). This law is meant to guide for states to create or expand SSPs, which are designed to reduce the spread of infectious diseases and reduce the risk of overdose among people who use drugs.
Expanding Number of Hospitals and Healthcare Facilities - For instance, a January 2020 report stated that China intends to invest USD 32 million in the development of hospitals in Wuhan. Also, India's Pradhan Mantri-Ayushman Bharat Health Infrastructure Mission was approved for a USD 1 billion loan by the World Bank in July 2022. Rapid medical advancements, such as better cures for diseases, the availability of lifesaving drugs, and the development of new treatment methods, have made healthcare services accessible to more people.
Rise in Number of Cancer Patients - As per CDC estimates, in 2019, there were 1,752,735 new cancer cases in the United States and 599,589 deaths associated with cancer. In addition, WHO reports that cancer accounted for nearly 10 million deaths worldwide in 2020. Cancer patients often require frequent injections of medication to manage their condition. Hypodermic needles are the most common tool used for this purpose.

Challenges

Stringent regulations imposed by the government - The government is concerned with the potential health and safety risks associated with these products, so they have implemented strict regulations to ensure that they are manufactured and distributed safely. This has triggered increased costs for manufacturers and distributors, which has in turn driven up prices for consumers.
High cost of hypodermic needles
Lack of availability of disposable needles

Global Hypodermic Needles Market Segmentation

The global hypodermic needles market is segmented and analyzed for demand and supply by product type into safety hypodermic needles, and non-safety hypodermic needles. Out of these, the safety hypodermic needles segment is estimated to gain the largest market share of about ~56% in the year 2035. The growth of the segment can be attributed to the increasing demand for safety needles in hospitals and clinics, as well as the growing awareness among healthcare professionals about the need for safe and hygienic practices, which is driving the growth of this segment. Additionally, the rising incidence of needle-stick injuries has resulted in the adoption of safety needles to reduce the risk and ensure patient safety. In Accordance with the CDC, the number of injuries caused by contaminated needles and other sharp devices among hospital-based healthcare personnel exceeds 385,000 injured every year. This equates to over 1,000 injuries a day.

The global hypodermic needles market is segmented and analyzed for demand and supply by application into drug delivery, vaccination, blood specimen collection. Out of these, the drug delivery segment is estimated to gain a significant market share of about ~46% in the year 2035. The growth of the segment can be attributed to the rising prevalence of chronic diseases, increasing adoption of injectable drugs, and growing demand for self-administration of drugs by patients, which is encouraging the manufacturers to focus on product innovation and development. Additionally, technological advancements in injection devices are also expected to drive the drug delivery segment growth. Furthermore, the presence of a wide range of advanced injection devices such as auto-injectors, pen injectors, and jet injectors is expected to contribute to segment growth.

Our in-depth analysis of the global hypodermic needles market includes the following segments:

By Product Type	Safety Hypodermic Needles Non-safety Hypodermic Needles
By Application	Drug Delivery Vaccination Blood Specimen Collection
By End User	Hospital Diabetic Patients Ambulatory Surgical Centers Family Practitioners Psychiatry Others

Global Hypodermic Needles Market Regional Synopsis

The share of hypodermic needles market in North America, amongst the market in all the other regions, is projected to be the largest with a share of about ~37% by the end of 2035. The growth of the market can be attributed majorly to the increasing prevalence of chronic diseases such as diabetes and cardiovascular diseases, along with the rising geriatric population in the region. According to the Centers for Disease Control and Prevention's latest findings, approximately 37.3 million people in the US have diabetes, which represents 11.3% of the total population of the country. There are 28.7 million people diagnosed with diabetes, including 28.5 million adults and a total of 96 million people have prediabetes who are 18 years old or older. Hypodermic needles are effective tools for treating diabetes as they allow precise delivery of insulin directly into the bloodstream. This helps to regulate blood sugar levels safely and efficiently. In addition, technological advancements in the production of hypodermic needles, as well as increasing awareness among healthcare personnel, are also expected to contribute to market growth.

The Asia Pacific hypodermic needles market is estimated to be the second largest, registering a share of about ~27% by the end of 2035. The growth of the market can be attributed majorly to the increasing demand for safety needles and the increasing number of hospitals in the region. Rising awareness about the risks of infections and the need for sterility in medical procedures has driven the demand for hypodermic needles as they are designed to reduce the risk of infection. Additionally, the increasing number of healthcare facilities and the presence of major pharmaceutical companies in the region are expected to drive market growth. With the growing population in the region, there is an increased need for healthcare facilities such as hospitals, clinics, and medical practices to serve the growing demand for medical services. Healthcare facilities need hypodermic needles for a variety of medical procedures, from administering vaccines to drawing blood.

Further, the hypodermic needles market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market can be attributed majorly to the increasing number of surgeries and the rising use of disposable needles in healthcare settings to minimize the risk of infection among patients. Additionally, the growing demand for minimally invasive surgeries, the rising popularity of self-administered drug delivery systems, and the increasing number of biopharmaceutical companies are expected to boost the demand for hypodermic needles in Europe. Self-administration of drugs provides people with a more convenient and cost-effective way to administer medication and perform medical procedures. Additionally, they reduce the risk of errors and reduce the amount of time it takes to administer medications and treatments. Furthermore, favorable government policies such as reimbursement for medical devices and increasing healthcare expenditure are expected to drive market growth in the region.

Get more information on this report: Request Free Sample PDF

Top Featured Companies Dominating the Global Hypodermic Needles Market

Becton
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Dickinson And Company
B. Braun Melsungen AG
Catalent Inc.
Medtronic plc
Retractable Technologies, Inc.
Smiths Group plc.
Connecticut Hypodermics Inc.
EXELINT International Co.
MedPro Safety Products Inc.

In The News

An international medical technology company, Becton, Dickinson & Company, introduced an increase in manufacturing capacity and domestic supply of safety injection devices for the U.S. government.
Medical device manufacturer Smiths Medical announced a strategic public-private partnership with the Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) and Biomedical Advanced Research and Development Authority (BARDA). As part of the partnership between BARDA and JPEO-CBRND, USD 20 million was invested for an increase in the production of syringes and needle devices for the Operation Warp Speed vaccine program.

Global Economic Impact

Request Insights

Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the hypodermic needles market?

Ans: Increasing prevalence of chronic diseases such as diabetes and cancer, and the growing demand for self-administered injections are the major factors driving the market growth.

2) What would be the CAGR of hypodermic needles market over the forecast period?

Ans: The market size of hypodermic needles is anticipated to attain a CAGR of ~4% over the forecast period, i.e., 2023 – 2035.

3) What are the challenges affecting the hypodermic needles market growth?

Ans: Lack of availability of disposable needles, and the stringent regulations imposed by the government are estimated to be the growth hindering factors for the market expansion.

4) Which region will provide more business opportunities for growth of hypodermic needles market in future?

Ans: The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

5) Who are the major players dominating the hypodermic needles market?

Ans: The major players in the market are Becton, Dickinson And Company, B. Braun Melsungen AG, Catalent Inc., Medtronic plc, Retractable Technologies, Inc., Smiths Group plc., Connecticut Hypodermics Inc., EXELINT International Co., MedPro Safety Products Inc., and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the hypodermic needles market?

Ans: The market is segmented by product type, application, end user, and by region.

8) Which segment captures the largest market size in the product type segment in the hypodermic needles market?

Ans: The safety hypodermic segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Base Year	2022
Forecast Year	2023-2035
CAGR	~4%
Base Year Market Size (2022)	~ USD 4 Billion
Forecast Year Market Size (2035)	~ USD 9 Billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)